v3.26.1
Consolidated Statements of Comprehensive (Loss) Income - USD ($)
$ in Thousands
 6 Months Ended 12 Months Ended
Dec. 31, 2024
Dec. 31, 2025
Jun. 30, 2024
Expenses      
General and administrative $ 5,472 $ 10,614 $ 16,410
Demonstration Plant operations 1,838 4,464 7,324
Management and directors' fees 986 2,216 2,489
Share-based compensation 2,091 6,589 7,937
Separation benefits 1,295 152  
Other   25  
Foreign exchange loss (gain) (316) 3,329 (639)
Loss from operations 11,366 27,389 33,521
Gain on deconsolidation of subsidiaries     164,099
Impairment expense (19,676) (26,468)  
Investment loss from Smackover Lithium (707) (6,358) (158)
Fair value gain on financial asset - FID 1,052 4,161 391
Fair value gain on Investment in Aqualung   2,742  
Interest and other income 232 1,857 922
Interest expense (27) (33) (62)
Net (loss) income before income taxes (30,492) (51,488) 131,671
Deferred income tax benefit (expense) 981 3,090 (25,870)
Net (loss) income (29,511) (48,398) 105,801
Item that may be reclassified subsequently to income or loss:      
Currency translation differences of foreign operations (562) 3,649 (775)
Total comprehensive (loss) income $ (30,073) $ (44,749) $ 105,026
Weighted average number of common shares outstanding - Basic 185,600,192 206,372,978 176,930,274
Weighted average number of common shares outstanding - Diluted 185,600,192 206,372,978 179,419,385
Basic (loss) earnings per share (in USD per share) $ (0.16) $ (0.23) $ 0.6
Diluted (loss) earnings per share (in USD per share) $ (0.16) $ (0.23) $ 0.59